ClinConnect ClinConnect Logo
Search / Trial NCT06896383

Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis

Launched by ASSIUT UNIVERSITY · Mar 24, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

Autoimmune hepatitis (AIH) is a rare and chronic inflammatory disease of the liver of unknown etiology characterized by loss of immune tolerance against liver antigens leading to progressive destruction of hepatic parenchyma and if untreated leads to end-stage liver disease.

It affects all ages with a peak incidence in pediatric age, where it is referred to as Juvenile Autoimmune Hepatitis (JAIH).JAIH is a long-term condition that varies in intensity over time. It occurs more frequently in females and is marked by increased levels of serum gamma globulins, the presence of autoantibodies in...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged between one day and 18 years (children)
  • patients diagnosed clinically and physically with juvenile autoimmune hepatitis including seronegative autoimmune hepatitis cases
  • Exclusion Criteria:
  • 1. Cases with inadequate tissue in the paraffin block
  • 2. Children with viral hepatitis
  • 3. patients above the age of 18 years old

Trial Officials

Howadya Ismail Hassan El Sayed, PhD

Study Director

Assiut University

Moemen Mostafa Ahmed Hafez, PhD

Study Director

Assiut University

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported